Dindigul Farm Product Promoter Fails to File Mandatory Share Sale Disclosure

SEBIEXCHANGE
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Dindigul Farm Product Promoter Fails to File Mandatory Share Sale Disclosure

Dindigul Farm Product Ltd has reported that its promoter, Indrayani Biotech Limited, sold 4,48,000 shares on September 30, 2026, without providing mandatory prior intimation or Form C disclosures. The company is actively pursuing the promoter for compliance under SEBI insider trading norms.

Dindigul Farm Product Promoter Disclosure Lapse

4,48,000 shares disposed by promoter Indrayani Biotech on September 30, 2026.
Non-compliance with SEBI (Prohibition of Insider Trading) regulations regarding mandatory disclosure filings.
Reader Takeaway: Promoter share disposal went undisclosed; company is enforcing SEBI compliance protocols to ensure corporate governance standards.

What just happened

Dindigul Farm Product Ltd notified the stock exchange regarding a governance lapse involving its promoter, Indrayani Biotech Limited. Following verification with the company's Registrar and Share Transfer Agent, it was confirmed that the promoter offloaded 4,48,000 equity shares on September 30, 2026, without fulfilling mandatory regulatory filing obligations.

Why this matters

Under SEBI (Prohibition of Insider Trading) Regulations, 2015, promoters are required to provide prior intimation and file Form C disclosures when trading company shares. The failure to do so raises concerns regarding transparency and compliance. Such lapses impact investor confidence and trigger mandatory scrutiny from the exchange.

Company Actions and Communications

The company acted to address the oversight by contacting the promoter via email on October 5, 2026, requesting an immediate explanation and the filing of all missing documentation. While the promoter's secretary communicated that filings would be completed by October 7, 2026, the company officially noted that as of October 6, 2026, no such disclosures had been received. The company has publicly affirmed its commitment to taking further corrective action under SEBI Regulation 7(2).

Risks to watch

Investors should monitor the situation for the eventual filing of the disclosures. Continued delay or failure to resolve the compliance gap may invite regulatory scrutiny or further punitive measures by exchange authorities against the promoter involved.

What to track next

Watch for the subsequent exchange filing from the company confirming the receipt of Form C and any additional updates regarding corrective governance measures taken against the promoter.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.